Reactive nitrogen intermediates and the pathogenesis of Salmonella and Mycobacteria

Current Opinion in Microbiology

Volumn 3, Issue 1, 2000, Pages 35-42

  Shiloh, Michael U ^a   Nathan, Carl F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN DERIVATIVE; REACTIVE OXYGEN METABOLITE;

BACTERIAL VIRULENCE; GENETIC ASSOCIATION; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TUBERCULOSIS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MAMMALIA; MURINAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0033968059     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)00048-X     Document Type: Review

References (76)

1. Nathan C. Perspective series: nitric oxide and nitric oxide synthases. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 100:1997;2417-2423.
2. Shiloh M.U., MacMicking J.D., Nicholson S., Brause J.E., Potter S., Marino M., Fang F., Dinauer M., Nathan C. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity. 10:1999;29-38. Mice deficient in both phagocyte oxidase (phox) and inducible nitric oxide synthase (NOS2) had a phenotype distinct from that of either parental strain or any other reported strain that mobilizes normal numbers of phagocytes: marked susceptibility to spontaneous infections from commensal organisms. However, these mice and their macrophages retained some ability to kill Listeria, Salmonella and E. coli, establishing definitively the existence of macrophage antimicrobial mechanisms independent of both phox and NOS2.
3. MacMicking J.D., North R.J., La Course R., Mudgett J.S., Shah S.K., Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA. 94:1997;5243-5248.
4. Adams L.B., Dinauer M.C., Morgenstern D.F., Krahenbuhl J.L. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tub Lung Dis. 78:1997;237-246.
5. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87. This seminal paper provides evidence that NOS2 can produce autocrine or paracrine signals to stimulate natural killer cell maturation and production of IFNγ, thereby contributing indirectly to the early containment of Leishmania major infection in mice.
6. Diefenbach A., Schindler H., Röllinghoff M., Yokoyama W.M., Bogdan C. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science. 284:1999;951-955. [Published erratum appears in Science 1999, 284:1776]. A novel molecular mechanism is defined for the effect of nitric oxide on interleukin-12 signaling in natural killer cells via stimulation of Tyk2 autokinase activity and STAT4 phosphorylation.
7. Weinrauch Y., Zychlinsky A. The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol. 53:1999;155-187.
8. Hersh D., Monack D.M., Smith M.R., Ghori N., Falkow S., Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA. 96:1999;2396-2401.
9. Kim Y.M., Talanian R.V., Li J., Billiar T.R. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J Immunol. 161:1998;4122-4128. This paper demonstrates that NO can regulate interleukin (IL)-1β and IL-18 production by macrophages by inhibiting the proteolytic activity the IL-1β converting enzyme, caspase-1. This inhibition is mediated by S-nitrosylation of caspase-1.
10. Brune B., von Knethen A., Sandau K.B. Nitric oxide and its role in apoptosis. Eur J Pharmacol. 351:1998;261-272.
11. Huang F.P., Niedbala W., Wei X.Q., Xu D., Feng G.J., Robinson J.H., Lam C., Liew F.Y. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol. 28:1998;4062-4070.
12. Bingisser R.M., Tilbrook P.A., Holt P.G., Kees U.R. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol. 160:1998;5729-5734.
13. MacFarlane A.S., Schwacha M.G., Eisenstein T.K. In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun. 67:1999;891-898.
14. Schwacha M.G., Meissler J.J. Jr., Eisenstein T.K. Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway. Infect Immun. 66:1998;5862-5866.
15. Sciorati C., Rovere P., Ferrarini M., Paolucci C., Heltai S., Vaiani R., Clementi E., Manfredi A.A. Generation of nitric oxide by the inducible nitric oxide synthase protects gamma delta T cells from Mycobacterium tuberculosis-induced apoptosis. J Immunol. 163:1999;1570-1576.
16. Hierholzer C., Harbrecht B., Menezes J.M., Kane J., MacMicking J., Nathan C.F., Peitzman A.B., Billiar T.R., Tweardy D.J. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med. 187:1998;917-928.
17. Long R., Light B., Talbot J.A. Mycobacteriocidal action of exogenous nitric oxide. Antimicrob Agents Chemother. 43:1999;403-405.
18. Weinberg J.B. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med. 4:1998;557-591. Thorough review of the evidence for RNI production by human monocytes/macrophages.
19. Shiloh M.U., Nathan C. Antimicrobial mechanisms of macrophages. Gordon S. Phagocytosis:The Host. 1999;407-439 JAI Press, London. [Advances in Cell and Molecular Biology of Membranes and Organelles vol 5.].
20. Nicholson S., Bonecini-Almeida MdG., Lapa de Silva J.R., Nathan C., Xie Q-W., Mumford R., Weidner J-R., Calaycay J., Geng J., Boechat N.et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 183:1996;2293-2302.
21. Nozaki Y., Hasegawa Y., Ichiyama S., Nakashima I., Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 65:1997;3644-3647.
22. Wang C.H., Liu C.Y., Lin H.C., Yu C.T., Chung K.F., Kuo H.P. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J. 11:1998;809-815.
23. Kwon O.J. The role of nitric oxide in the immune response of tuberculosis. J Korean Med Sci. 12:1997;481-487.
24. Rich E.A., Torres M., Sada E., Finegan C.K., Hamilton B.D., Toossi Z. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber Lung Dis. 78:1997;247-255.
25. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T.et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:1999;732-736. The Toll-like receptor 2 (TLR2) is implicated in the activation of mouse and human macrophages in response to mycobacterial and other lipoproteins, including activation of human macrophages to produce nitric oxide.
26. Ting L.M., Kim A.C., Cattamanchi A., Ernst J.D. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol. 163:1999;3898-3906.
27. Fang F.C. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 99:1997;2818-2825. An excellent review detailing microbial resistance mechanisms to reactive nitrogen intermediates as reported through 1997.
28. Mouy R., Fischer A., Vilmer E., Seger R., Griscelli C. Incidence, severity and prevention of infections in chronic granulomatous disease. J Pediatr. 114:1989;555-560.
29. Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 73:1993;469-485.
30. Gruenheid S., Pinner E., Desjardins M., Gros P. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med. 185:1997;717-730.
31. Hackam D.J., Rotstein O.D., Zhang W., Gruenheid S., Gros P., Grinstein S. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med. 188:1998;351-364.
32. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
33. Fleming M.D., Trenor C.C. III, Su M.A., Foernzler D., Beier D.R., Dietrich W.F., Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 16:1997;383-386.
34. Zwilling B.S., Kuhn D.E., Wikoff L., Brown D., Lafuse W. Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect Immun. 67:1999;1386-1392.
35. North R.J., Medina E. How important is Nramp1 in tuberculosis? Trends Microbiol. 6:1998;441-443.
36. Blackwell J.M., Black G.F., Peacock C.S., Miller E.N., Sibthorpe D., Gnananandha D., Shaw J.J., Silveira F., Lins-Lainson Z., Ramos F.et al. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Philos Trans R Soc Lond B Biol Sci. 352:1997;1331-1345.
37. Bellamy R., Ruwende C., Corrah R., McAdam K.P.W.J., Whittle H.C., Hill A.V.S. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med. 338:1998;640-644.
38. •], implicates mutations in either interleukin-12 or its receptor in human susceptibility to infections by both mycobacteria and Salmonella.
39. •].
40. •].
41. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 335:1996;1941-1949.
42. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., Levin M., Blanche S., Seboun E., Fischer A.et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med. 335:1996;1956-1961.
43. •], along with earlier work, implicate interferon-γ-receptor mutations in human susceptibility to mycobacterial infections.
44. •].
45. Burgner D., Xu W., Rockett K., Gravenor M., Charles I.G., Hill A.V., Kwiatkowski D. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet. 352:1998;1193-1194. [letter] [see comments].
46. Kun J.F., Mordmuller B., Lell B., Lehman L.G., Luckner D., Kremsner P.G. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet. 351:1998;265-266. [letter] [see comments].
47. Bellamy R., Ruwende C., Corrah T., McAdam K.P., Thursz M., Whittle H.C., Hill A.V. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 179:1999;721-724.
48. Rockett K.A., Brookes R., Udalova I., Vidal V., Hill A.V., Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 66:1998;5314-5321.
49. De Groote M.A., Ochsner U.A., Shiloh M.U., Nathan C., McCord J.M., Dinauer M.C., Libby S.J., Vazquez-Torres A., Xu Y., Fang F.C. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci USA. 94:1997;13997-14001.
50. Farrant J.L., Sansone A., Canvin J.R., Pallen M.J., Langford P.R., Wallis T.S., Dougan G., Kroll J.S. Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol Microbiol. 25:1997;785-796.
51. Fang F.C., DeGroote M.A., Foster J.W., Baumler A.J., Ochsner U., Testerman T., Bearson S., Giard J., Xu Y., Campbell G.et al. Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc Natl Acac Sci USA. 96:1999;7502-7507.
52. Figueroa-Bossi N., Bossi L. Inducible prophages contribute to Salmonella virulence in mice. Mol Microbiol. 33:1999;167-176.
53. Nunoshiba T., De Rojas-Walker T., Tannenbaum S.R., Demple B. Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages. Infect Immun. 63:1995;794-798.
54. Fang F.C., Vasquez-Torres A., Xu Y. The transcriptional regulator SoxS is required for resistance of Salmonella typhimurium to paraquat but not for virulence in mice. Infect Immun. 65:1997;5371-5375.
55. Zheng M., Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science. 279:1998;1718-1721.
56. Hausladen A., Privalle C.T., Keng T., De Angelo J., Stamler J.S. Nitrosative stress: activation of the transcription factor OxyR. Cell. 86:1996;719-729.
57. Chen L., Xie Q.W., Nathan C. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell. 1:1998;795-805. Genetic and physiological evidence is provided showing that ahpC from Mycobacterium tuberculosis and Salmonella typhimurium can protect bacterial and mammalian cells from reactive-nitrogen-intermediate-mediated cytotoxicity.
58. Chae H.Z., Robison K., Poole L.B., Church G., Storz G., Rhee S.G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA. 91:1994;7017-7021.
59. Taylor P.D., Inchley C.J., Gallagher M.P. The Salmonella typhimurium AhpC polypeptide in not essential for virulence in BALB/c mice but is recognized as an antigen during infection. Infect Immun. 66:1998;3208-3217.
60. Heym B., Stavropoulos E., Honore N., Domenech P., Saint-Joanis B., Wilson T.M., Collins D.M., Colston M.J., Cole S.T. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun. 65:1997;1395-1401.
61. Poole R.K., Anjum M.F., Membrillo-Hernandez J., Kim S.O., Hughes M.N., Stewart V. Nitric oxide, nitrite, Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12. J Bacteriol. 178:1996;5487-5492.
62. Crawford M.J., Goldberg D.E. Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. J Biol Chem. 273:1998;34028-34032.
63. 2 or the peroxynitrite generator, SIN-1. However, a role for hmp in pathogenicity of Salmonella was not described.
64. •], demonstrates that E. coli flavohemoglobin encoded by hmp can act as a dioxygenase, protecting bacteria by detoxifying nitric oxide to nitrite and nitrate. In addition, expression of hmp protects E. coli under anaerobic conditions, suggesting alternative mechanisms.
65. •].
66. Hu Y., Butcher P.D., Mangan J.A., Rajandream M.A., Coates A.R. Regulation of hmp gene transcription in Mycobacterium tuberculosis: effects of oxygen limitation and nitrosative and oxidative stress. J Bacteriol. 181:1999;3486-3493.
67. Lundberg B.E., Wolf R.E. Jr., Dinauer M.C., Xu Y., Fang F.C. Glucose 6-phosphate dehydrogenase is required for Salmonella typhimurium virulence and resistance to reactive oxygen and nitrogen intermediates. Infect Immun. 67:1999;436-438.
68. Sherman D.R., Mdluli K., Hickey M.J., Arain T.M., Morris S.L., Barry C.E. III, Stover C.K. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science. 272:1996;1641-1643.
69. Buchmeier N.A., Libby S.J., Xu Y., Loewen P.C., Switala J., Guiney D.G., Fang F.C. DNA repair is more important than catalase for Salmonella virulence in mice. J Clin Invest. 95:1995;1047-1053.
70. Manca C., Paul S., Barry C.E. III, Freedman V.H., Kaplan G. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun. 67:1999;74-79.
71. Buchmeier N.A., Lipps C.J., So M.Y., Heffron F. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol Microbiol. 7:1993;933-936.
72. Ehrt S., Shiloh M.U., Ruan J., Choi M., Gunzburg S., Nathan C., Xie Q., Riley L.W. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med. 186:1997;1885-1896.
73. Ruan J., St John G., Ehrt S., Riley L., Nathan C. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect Immun. 67:1999;3276-3283.
74. Garbe T.R., Hibler N.S., Deretic V. Response to reactive nitrogen intermediates in mycobacterium tuberculosis: induction of the 16-kilodalton a-crystallin homolog by exposure to nitric oxide donors. Infect Immunol. 67:1999;460-465.
75. Yuan Y., Crane D., Simpson R.M., Zhu Y., Hickey M.J., Sherman D.R., Barry C.E. III The 16-kDA a-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA. 95:1998;9578-9583.
76. Chiang S.L., Mekalanos J.J., Holden D.W. In vivo genetic analysis of bacterial virulence. Annu Rev Microbiol. 53:1999;129-154.